Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

402
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
402
Hypertension I: Introduction01:28

Hypertension I: Introduction

813
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
813
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

902
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
902
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.0K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

604
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
604
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

494
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
494

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same author

Healthcare Insurance Status and Hypertension Control Before and After the Affordable Care Act.

American journal of hypertension·2026
Same author

Predicted Cardiovascular and Economic Impacts of the Measure Accurately, Act Rapidly, and Partner With Patients Program to Improve Hypertension Control.

American journal of preventive medicine·2025
Same author

Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Non-debatable issues in defining blood pressure targets for hypertension - Editorial.

Blood pressure·2025
Same author

Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control.

Hypertension (Dallas, Tex. : 1979)·2025

Related Experiment Video

Updated: Jan 27, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.3K

Adherence in Hypertension.

Michel Burnier1, Brent M Egan2

  • 1From the Service of Nephrology and Hypertension, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (M.B.).

Circulation Research
|March 29, 2019
PubMed
Summary
This summary is machine-generated.

Poor adherence to hypertension medication is a major cause of uncontrolled blood pressure. Addressing patient adherence is crucial for managing hypertension effectively and reducing cardiovascular risks.

Keywords:
blood pressurecardiovascular diseasesdrug monitoringhypertensionprevalenceresistant hypertension

More Related Videos

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.2K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

771

Related Experiment Videos

Last Updated: Jan 27, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

16.3K
Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.2K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

771

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Hypertension is a leading global cause of noncommunicable disease deaths, largely uncontrolled worldwide.
  • Suboptimal adherence to pharmacotherapy significantly contributes to poor blood pressure control in hypertensive patients.
  • Adherence issues encompass failure to initiate, maintain, or persist with prescribed antihypertensive medications.

Purpose of the Study:

  • To highlight the critical role of adherence in hypertension management.
  • To identify factors contributing to medication nonadherence in hypertension.
  • To emphasize the importance of addressing adherence in clinical practice and guidelines.

Main Methods:

  • Review of factors associated with medication nonadherence in hypertension.
  • Discussion of monitoring strategies for adherence in high-risk patients.
  • Analysis of current approaches to improve adherence in hypertension management.

Main Results:

  • Multiple factors (demographic, socioeconomic, medical, therapy-related, healthcare system, patient-specific) are linked to nonadherence.
  • Electronic and biochemical monitoring can detect and improve adherence in high-risk individuals.
  • Focusing on adherence is essential given the lack of new antihypertensive drugs.

Conclusions:

  • Understanding adherence barriers is key to managing hypertension.
  • Enhanced monitoring and accessibility of adherence measures offer future opportunities.
  • Healthcare providers must prioritize drug adherence as a major component of hypertension management.